SOURCES:
Lindi Campbell, lung most cancers advocate, Lexington, KY.
Alice Berger, PhD, assistant professor, Human Biology Division, Fred Hutchinson Most cancers Analysis Middle.
Ramaswamy Govindan, MD, professor of medication (medical oncology); Anheuser Busch endowed chair in medical oncology, Washington College Faculty of Medication, St. Louis.
Pleasure Feliciano, MD, affiliate professor of oncology, Johns Hopkins College Faculty of Medication.
Roy Herbst, MD, PhD, Ensign professor of medication (medical oncology) and professor of pharmacology, Yale Faculty of Medication; director, Middle for Thoracic Cancers; chief of medical oncology, Yale Most cancers Middle and Smilow Most cancers Hospital; affiliate most cancers heart director, translational science.
Missouri Medication: “Lung Most cancers in Non-People who smoke.”
CDC: “Nationwide Middle for Well being Statistics — Glossary,” “Lung Most cancers — Who Ought to Be Screened for Lung Most cancers?”
Journal of Medical Oncology: “Lung Most cancers in By no means People who smoke: A Assessment,” “Genomic Profiling of Lung Adenocarcinoma in By no means-People who smoke.”
Memorial Sloan Kettering Most cancers Middle: “Lung Most cancers Genomic Testing (EGFR, KRAS, ALK).”
American Most cancers Society: “Information & Figures 2021 Stories One other Document-Breaking 1-12 months Drop in Most cancers Deaths,” “Focused Drug Remedy for Non-Small Cell Lung Most cancers,” “Immunotherapy for Non-Small Cell Lung Most cancers.”
American Lung Affiliation: “New Report: Kentucky Has Highest Lung Most cancers Charges within the Nation, Backside of Listing in Survival, Early Analysis.”
Individuals: “Dana Reeve Courageous to the Finish.”
